BioSpace News Archive

Policy

NanoViricides has Requested a Pre-IND Meeting with the US FDA

NanoViricides, Inc. a company with novel platform technology to treat difficult and life-threatening viral diseases, announces that it has requested a pre-IND meeting with the US FDA, as it progresses its lead drug candidate towards human clinical trials.

March 26, 2019
·
9 min read
Deals

Realm Therapeutics Announces Cancellation of AIM Listing

Realm Therapeutics plc announced on March 15, 2019 that the listing of the Company’s Ordinary Shares on AIM will cease and cancellation will be effective from 7:00 a.m. on March 27, 2019.

March 26, 2019
·
2 min read
Business

Ichor Medical Systems Announces Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform

Ichor® Medical Systems, Inc. announced that it has entered into a collaboration and research license agreement with AstraZeneca for the development and clinical assessment of plasmid DNA constructs.

March 26, 2019
·
2 min read
Deals

Exicure to Present at Spring Investor Summit 2019

Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced that its CFO, David Snyder, will give a company presentation on Tuesday, April 2, 2019 at 9:30 am ET at the Spring Investor Summit.

March 26, 2019
·
1 min read
Drug Development

Moleculin Announces Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in the US and in Poland

One patient to proceed to potentially curative bone marrow transplant; no cardiotoxicity observed

March 26, 2019
·
7 min read
ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019

Company to showcase innovative programs addressing urgent need for disease-modifying therapies selectively targeting toxic oligomers in Alzheimer’s and Parkinson’s diseases and ALS

March 26, 2019
·
2 min read
Business

Patients with hemophilia A benefit from preventive use of newer FDA-approved extended half-life therapies

Study compared therapies in areas of efficacy, safety, cost and use

March 26, 2019
·
4 min read
CannaTech Tel Aviv 2019 Schedule April 1-2

Showcasing Biggest Industry Leaders in Business, Medical Science & Technology in Tel Aviv, the World Capital of Medical Cannabis Innovation

March 26, 2019
·
5 min read
Job Trends

Lipocine Late-Breaker Presentation at EASL Meeting to Detail LPCN 1144 MRI-PDFF Based Clinical Results on Reduction of Liver Fat and Key Serum Biomarkers

Lipocine Inc., a specialty pharmaceutical company, announced acceptance of their abstract for late-breaker presentation on LPCN 1144 clinical results as part of The International Liver Congress™ 2019, the annual meeting of the European Association for the Study of the Liver.

March 26, 2019
·
3 min read
Biotech Bay

Eiger BioPharmaceuticals to Participate in Conferences in April

Eiger BioPharmaceuticals, Inc. announced that management will present at upcoming investor, scientific, and orphan drug conferences in April.

March 26, 2019
·
4 min read